Medicare Enrolled
Dr. Alec Platt, M.D
Pulmonary Disease · Schenectody, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Platt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Platt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Platt
Dr. Alec Platt is a pulmonary disease specialist in Schenectody, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Platt performed 1,660 Medicare services across 1,167 unique beneficiaries.
Between the years covered by Open Payments, Dr. Platt received a total of $8,190 from 48 pharmaceutical and/or device companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Platt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in NY
$8,190 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,660
Medicare services
Top 25% in NY for pulmonary disease
1,167
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~87 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
451 | $90 | $151 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
360 | $2 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $62 | $134 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
159 | $163 | $412 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
146 | $125 | $294 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $88 | $191 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
46 | $31 | $64 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
46 | $40 | $86 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
34 | $28 | $90 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
25 | $87 | $470 |
| New patient office visit, complex (60-74 min) | 17 | $141 | $326 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $101 | $247 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
15 | $94 | $682 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
13 | $15 | $43 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
11 | $31 | $152 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,190
Total received (2018-2024)
Avg $1,170/year across 7 years
Top 22% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,190 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,594
2023
$1,121
2022
$248
2021
$802
2020
$1,235
2019
$1,414
2018
$1,775
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$257
GlaxoSmithKline, LLC.
$244
Regeneron Healthcare Solutions, Inc.
$208
Avadel CNS Pharmaceuticals, LLC
$168
Harmony Biosciences Llc
$147
GENZYME CORPORATION
$107
Mylan Specialty L.P.
$63
JAZZ PHARMACEUTICALS INC.
$61
Axsome Therapeutics, Inc.
$42
Novartis Pharmaceuticals Corporation
$39
United Therapeutics Corporation
$36
Insmed, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Vifor Pharma, Inc.
$30
Merck Sharp & Dohme LLC
$28
ANI Pharmaceuticals, Inc.
$21
HARMONY BIOSCIENCES LLC
$19
Paratek Pharmaceuticals, Inc.
$19
Actelion Pharmaceuticals US, Inc.
$15
Inspire Medical Systems, Inc.
$15
Grifols USA, LLC
$14
Top 3 companies account for 44.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,794
AstraZeneca Pharmaceuticals LP
$980
Boehringer Ingelheim Pharmaceuticals, Inc.
$693
Regeneron Healthcare Solutions, Inc.
$379
Jazz Pharmaceuticals Inc.
$324
Mylan Specialty L.P.
$287
Philips Electronics North America Corporation
$286
GENZYME CORPORATION
$283
Janssen Pharmaceuticals, Inc
$276
Harmony Biosciences LLC
$244
Grifols USA, LLC
$217
JAZZ PHARMACEUTICALS INC.
$191
Avadel CNS Pharmaceuticals, LLC
$187
Genentech USA, Inc.
$170
Harmony Biosciences Llc
$147
Novartis Pharmaceuticals Corporation
$142
Pulmonx Corporation
$130
Merck Sharp & Dohme Corporation
$109
Takeda Pharmaceuticals U.S.A., Inc.
$106
Insmed, Inc.
$97
Teva Pharmaceuticals USA, Inc.
$93
United Therapeutics Corporation
$91
Axsome Therapeutics, Inc.
$83
Actelion Pharmaceuticals US, Inc.
$70
Shire North American Group Inc
$63
Sunovion Pharmaceuticals Inc.
$62
Electromed, Inc.
$58
Circassia Pharmaceuticals Inc
$51
Mallinckrodt LLC
$48
Astellas Pharma US Inc
$47
Merck Sharp & Dohme LLC
$46
PORTOLA PHARMACEUTICALS, INC.
$45
HARMONY BIOSCIENCES LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$37
PFIZER INC.
$37
Inspire Medical Systems, Inc.
$34
Mallinckrodt Hospital Products Inc.
$30
Vifor Pharma, Inc.
$30
E.R. Squibb & Sons, L.L.C.
$26
Alexion Pharmaceuticals, Inc.
$25
ADVANCED RESPIRATORY, INC
$25
Advanced Respiratory, Inc
$22
ANI Pharmaceuticals, Inc.
$21
Paratek Pharmaceuticals, Inc.
$19
Veran Medical Technologies, Inc.
$13
PORTOLA PHARMACEUTICALS, LLC
$12
Gilead Sciences, Inc.
$12
La Jolla Pharmaceutical Company
$11
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AMBISOME · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · CRESEMBA · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · GIAPREZA · GLASSIA · HYQVIA · INSPIRE · LONHALA MAGNAIR · LUMRYZ · NEXVIAZYME · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · ULTOMIRIS · Utibron · Veltassa · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
37
Per 100K population
23.2
County median income
$76,989
Nearest hospital
ELLIS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Platt is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Platt experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Platt performed 451 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Platt receive payments from pharmaceutical companies?
Yes. Dr. Platt received a total of $8,190 from 48 companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Platt's costs compare to other pulmonary diseases in Schenectody?
Dr. Platt's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Platt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Schenectody
Browse pulmonary diseases in Schenectody ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology